Although microarray data show that WNT MB has the highest expression of IGFBP2, WNT MBs have the most favorable prognosis and this is the only MB subgroup in which metastasis is not an indicative of poor prognosis [53, 65]. This evidence concerns the gene IGFBP2 and Mobius syndrome.